Published Jun 26, 2017
Robin Feldman on Drug Patents, Generics, and Drug Wars
Robin Feldman delves into the complex strategies pharmaceutical companies employ to sustain high drug prices and limit competition, scrutinizing tactics that exploit regulatory frameworks and delay generic entry, thus affecting consumers and market dynamics.
Topics covered
Popular Clips
Episode Highlights
Related Episodes
Robin Feldman on Drugs, Money, and Secret Handshakes
Answers 383 questions
Richard Epstein on Property Rights and Drug Patents
Answers 383 questions
Marcia Angell on Big Pharma
Answers 383 questions
Casey Mulligan on Vaccines, the Pandemic, and the FDA
Answers 383 questionsVinay Prasad on Pharmaceuticals, the FDA, and the Death of Duty
Answers 383 questionsRichard Epstein on Regulation
Answers 383 questions
Tom Wainwright on Narconomics
Answers 383 questionsVinay Prasad on Cancer Drugs, Medical Ethics, and Malignant
Answers 383 questions
Vincent Rajkumar on the High Price of Cancer Drugs
Answers 383 questions
Alex Tabarrok on Innovation
Answers 383 questions
Michele Boldrin on Intellectual Property
Answers 383 questions
Robin Hanson on Health
Answers 383 questions
Nicholas Wapshott on Samuelson and Friedman
Answers 383 questionsRichard Epstein on Legislators vs. Wal-Mart
Answers 383 questions
Eric Topol on the Creative Destruction of Medicine
Answers 383 questions